Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Practice Guidance
AASLD Practice Statement on the Evaluation and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Children
Resmetirom Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease: October 2024 Updates to AASLD Practice Guidance
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Update and Impact of New Nomenclature on the AASLD Clinical Practice Guidance on Nonalcoholic Fatty Liver Disease
AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease [updated 2023]
Supplemental Materials
This AACE guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders. It was co-sponsored by AASLD.